سعر فلدين جل 15 جرام 0.5% 2022

Piroxicam 0.5% topical gel (Pfizer), 15 g.

• Topical management of pain, inflammation or stiffness associated with osteoarthritis and acute musculoskeletal disorders (bursitis, periarthritis, tendonitis, post-traumatic conditions, sprains, lower back pain).Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland

• Local irritation, rash, possible photosensitivity; contact dermatitis and eczema (post-marketing); SJS/TEN very rarely; fixed drug eruption (frequency unknown).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Hypersensitivity to piroxicam or excipients; third trimester of pregnancy; children (no experience); patients in whom aspirin or other NSAIDs induce asthma, rhinitis or urticaria; open skin lesions, dermatoses or infection at the site.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Life-threatening skin reactions (SJS/TEN, DRESS) are reported with systemic piroxicam and cannot be ruled out topically — stop at first sign; fixed drug eruption reported; interstitial nephritis/nephrotic syndrome/renal failure reported with topical piroxicam (causality not established); caution with peptic ulcer, renal or hepatic disease; contains ethanol, propylene glycol and benzyl alcohol (local irritation).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Coumarin anticoagulants; aspirinPiroxicam is highly protein-bound (possible interaction with coumarin anticoagulants) and aspirin alters its handling; significant interactions are unlikely with topical use.Health Products Regulatory Authority (HPRA), Ireland

• Safety of topical piroxicam in pregnancy not established; in the first and second trimester use only if clearly necessary at the lowest dose for the shortest time.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Not recommended in nursing mothers as clinical safety has not been established (oral dosing gives milk levels about 1% of plasma).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Piroxicam: Inhibits cyclooxygenase, reducing prostaglandin synthesis and thereby inflammation and pain.